Latest News

WHO validated the elimination in June 2025, and Kenya made a national announcement in August 2025 before formally receiving the certification in Geneva.

Since the partnership began, Gilead has supplied more than 1.1 million vials of AmBisome and contributed over US$18 million in funding.

Idefirix is a first-in-class treatment designed to help highly sensitised adult kidney transplant patients who face difficulties finding compatible donors.

Yuhan operates two API manufacturing facilities in South Korea and has reported steady international growth, with overseas sales increasing 21% in the first quarter.

SmartIQ was developed in collaboration with leading cardiovascular centers to tackle one of the most persistent challenges in coronary imaging: balancing high-quality images with lower radiation exposure for both patients and healthcare professionals.

The acquisition reflects a long-term strategic collaboration between the two companies, with Artivion already serving as the exclusive distributor of NEXUS across Europe, the Middle East, and Africa since 2019.

The procedure, carried out in Damaturu, represents the first time such an advanced maxillofacial surgery has been conducted in a state-owned hospital in the region.

Owen Mumford brings established expertise in device design, precision moulding, and medical device assembly, which will now be integrated with Embecta’s commercial infrastructure and large-scale manufacturing capabilities.

The solution integrates Syngo.CT Coronary Cockpit on the Syngo.via platform with Syngo PCI Connect running on Artis angiography systems.

The funding comes as health authorities across the continent intensify efforts to contain the rapidly evolving outbreak linked to the Bundibugyo strain of the Ebola virus.